Protocol for discovering genetic variants associated with ATAC-seq footprint-inferred transcription factor binding
Transcription factor (TF) binding is detectable in assay for transposase-accessible chromatin using sequencing (ATAC-seq) experiments, where bound TFs block transposase insertions, leaving a depletion of insertions known as a "footprint." Here, we present a computational protocol for detecting genetic variants associated with footprint-inferred TF binding. We describe steps to run the PRINT footprinting software to quantify TF binding likelihood at variants across multiple genotyped ATAC-seq samples and then run regressions to measure genetic associations. This protocol can implicate causal variants in disease-associated loci. For complete details on the use and execution of this protocol, please refer to Dudek et al.<sup>1</sup>.
Authors
- Laura Almasy (ORCID: https://orcid.org/0000-0002-9184-8124)
- Benjamin Franklin Voight (ORCID: https://orcid.org/0000-0002-6205-9994)
- Max F. Dudek (ORCID: https://orcid.org/0000-0001-8521-9543)
- Struan F.A. Grant (ORCID: https://orcid.org/0000-0003-2025-5302)
- Brandon M. Wenz
Institutions
- Children's Hospital of Philadelphia (US)
- Translational Therapeutics (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- STAR Protocols
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.xpro.2025.104148
- Primary Topic
- Genomic variations and chromosomal abnormalities
- Type
- article
- Field-Weighted Citation Impact
- 0.00